ArticleCancer chemotherapy and pharmacology2026

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.

Jibran Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.